This entry was posted on April 2, 2009 at 10:12 pm and is filed under Plk1, Takeda.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
Interesting scaffold that is also being pursued by Vertex (see WO2007095188), AstraZeneca (WO2008003958) and Cyclacel (this week’s WO2009040556). Is everyone copying Vertex of did some disclosure evoke all these companies to explore such scaffolds?